SCHEMBL531088

SCHEMBL531088

Cc1ccccc1CNC1CCCC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
PKM P14618 1/20 0.51
HTT P42858 4/20 0.50
KMT2A Q03164 3/20 0.50
LMNA P02545 2/20 0.50
HPGD P15428 1/20 0.49
PABPC1 P11940 1/20 0.49
MEN1 O00255 2/20 0.48
ALDH1A1 P00352 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
GLA P06280 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
GAA P10253 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46
ALOX15 P16050 1/20 0.46
EPHX2 P34913 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11781117 0.98 HTT (0.50) KDM4EPKMHTTKMT2ALMNA
SCHEMBL9346814 0.98 KDM4E (0.53) KDM4EPKMHTTKMT2ALMNA
Hydrochloric Acid SCHEMBL11779650 0.96 KDM4E (0.52) KDM4EPKMHTTKMT2ALMNA
SCHEMBL2466537 0.92 ACHE (0.47) KDM4EPKMHTTKMT2ALMNA
Hydrochloric Acid SCHEMBL12813545 0.91 KMT2A (0.49) KDM4EPKMHTTKMT2ALMNA
SCHEMBL9278692 0.84 PABPC1 (0.49) KDM4EPKMHTTKMT2ALMNA
SCHEMBL8851140 0.84 ACHE (0.41) KDM4EPKMHTTKMT2ALMNA
SCHEMBL4214710 0.83 ACHE (0.47) KMT2AMEN1HRH3ACHE
Formic Acid SCHEMBL5085570 0.83 KMT2A (0.44) KDM4EPKMHTTKMT2AHPGD
SCHEMBL13011025 0.82 CYP2D6 (0.59) KDM4EPKMHTTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964693-A1 STORAGE STABLE FOAMABLE COMPOSITIONS CONTAINING 1,1,1,4,4,4-HEXAFLUORO-2-BUTENE Honeywell International Inc. (US) 2016-01-13 EP disclosed
WO-2014137969-A1 STORAGE STABLE FOAMABLE COMPOSITIONS CONTAINING 1,1,1,4,4,4-HEXAFLUORO-2-BUTENE HONEYWELL INTERNATIONAL INC. (US) 2014-09-12 WO disclosed
WO-2012015887-A2 FOAMS AND ARTICLES MADE FROM FOAMS CONTAINING 1-CHLORO-3,3,3-TRIFLUOROPROPENE (HCFO-1233ZD) HONEYWELL INTERNATIONAL INC. (US) 2012-02-02 WO disclosed
US-20070149560-A1 Novel fused triazolones and the uses thereof ASTRAZENECA AB (SE) 2007-06-28 US disclosed
US-20070149560-A1 Novel fused triazolones and the uses thereof ASTRAZENECA AB (SE) 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149560-A1 Novel fused triazolones and the uses thereof TP53, BRCA1, KLK3 KDM4E 3368/4885PKM 1374/4885HTT 2807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.